Email This Release
Abraxis BioScience Announces Agreement to Re-Acquire Exclusive U.S. Rights to ABRAXANE; Company Highlights Plans to Initiate Nine Pivotal Registrational Trials in 2009
*
marks required fields
Recipient Name:
*
Recipient Email:
Message:
